Singapore markets open in 5 hours 57 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,299.95 +53.27 (+1.02%) Dow
39,830.16 +272.05 (+0.69%) Nasdaq
16,725.63 +214.45 (+1.30%) Bitcoin USD
65,756.11 +4,373.47 (+7.12%) CMC Crypto 200
1,381.33 +113.38 (+8.94%)
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
As of 02:55PM EDT. Market open.
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 142.85M |
| Enterprise value | 116.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 7.31 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.88 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -41.37% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 9.1000 |
| 52-week low 3 | 3.4400 |
| 50-day moving average 3 | 4.1630 |
| 200-day moving average 3 | 5.8963 |
Share statistics
| Avg vol (3-month) 3 | 64.13k |
| Avg vol (10-day) 3 | 20.18k |
| Shares outstanding 5 | 35.62M |
| Implied shares outstanding 6 | 35.62M |
| Float 8 | 24.19M |
| % held by insiders 1 | 6.70% |
| % held by institutions 1 | 4.07% |
| Shares short (30 Apr 2024) 4 | 3.13k |
| Short ratio (30 Apr 2024) 4 | 0.05 |
| Short % of float (30 Apr 2024) 4 | 0.01% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.01% |
| Shares short (prior month 28 Mar 2024) 4 | 12.58k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | -246.24% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -30.89M |
| Net income avi to common (ttm) | -30.37M |
| Diluted EPS (ttm) | -1.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 35.91M |
| Total cash per share (mrq) | 1.25 |
| Total debt (mrq) | 9.56M |
| Total debt/equity (mrq) | 52.78% |
| Current ratio (mrq) | 1.95 |
| Book value per share (mrq) | 0.68 |
Cash flow statement
| Operating cash flow (ttm) | -22.24M |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.